Chionomys nivalis (European snow vole): 130863228
Help
Entry
130863228 CDS
T11437
Symbol
Casp3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
cnl Chionomys nivalis (European snow vole)
Pathway
cnl01524
Platinum drug resistance
cnl04010
MAPK signaling pathway
cnl04115
p53 signaling pathway
cnl04148
Efferocytosis
cnl04210
Apoptosis
cnl04215
Apoptosis - multiple species
cnl04623
Cytosolic DNA-sensing pathway
cnl04650
Natural killer cell mediated cytotoxicity
cnl04657
IL-17 signaling pathway
cnl04668
TNF signaling pathway
cnl04726
Serotonergic synapse
cnl04932
Non-alcoholic fatty liver disease
cnl04933
AGE-RAGE signaling pathway in diabetic complications
cnl04936
Alcoholic liver disease
cnl05010
Alzheimer disease
cnl05012
Parkinson disease
cnl05014
Amyotrophic lateral sclerosis
cnl05016
Huntington disease
cnl05020
Prion disease
cnl05022
Pathways of neurodegeneration - multiple diseases
cnl05132
Salmonella infection
cnl05133
Pertussis
cnl05134
Legionellosis
cnl05145
Toxoplasmosis
cnl05146
Amoebiasis
cnl05152
Tuberculosis
cnl05160
Hepatitis C
cnl05161
Hepatitis B
cnl05162
Measles
cnl05163
Human cytomegalovirus infection
cnl05164
Influenza A
cnl05165
Human papillomavirus infection
cnl05167
Kaposi sarcoma-associated herpesvirus infection
cnl05168
Herpes simplex virus 1 infection
cnl05169
Epstein-Barr virus infection
cnl05170
Human immunodeficiency virus 1 infection
cnl05200
Pathways in cancer
cnl05203
Viral carcinogenesis
cnl05205
Proteoglycans in cancer
cnl05206
MicroRNAs in cancer
cnl05210
Colorectal cancer
cnl05222
Small cell lung cancer
cnl05416
Viral myocarditis
cnl05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
cnl00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
130863228 (Casp3)
04668 TNF signaling pathway
130863228 (Casp3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
130863228 (Casp3)
09143 Cell growth and death
04210 Apoptosis
130863228 (Casp3)
04215 Apoptosis - multiple species
130863228 (Casp3)
04115 p53 signaling pathway
130863228 (Casp3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
130863228 (Casp3)
04650 Natural killer cell mediated cytotoxicity
130863228 (Casp3)
04657 IL-17 signaling pathway
130863228 (Casp3)
09156 Nervous system
04726 Serotonergic synapse
130863228 (Casp3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
130863228 (Casp3)
05206 MicroRNAs in cancer
130863228 (Casp3)
05205 Proteoglycans in cancer
130863228 (Casp3)
05203 Viral carcinogenesis
130863228 (Casp3)
09162 Cancer: specific types
05210 Colorectal cancer
130863228 (Casp3)
05222 Small cell lung cancer
130863228 (Casp3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
130863228 (Casp3)
05161 Hepatitis B
130863228 (Casp3)
05160 Hepatitis C
130863228 (Casp3)
05164 Influenza A
130863228 (Casp3)
05162 Measles
130863228 (Casp3)
05168 Herpes simplex virus 1 infection
130863228 (Casp3)
05163 Human cytomegalovirus infection
130863228 (Casp3)
05167 Kaposi sarcoma-associated herpesvirus infection
130863228 (Casp3)
05169 Epstein-Barr virus infection
130863228 (Casp3)
05165 Human papillomavirus infection
130863228 (Casp3)
09171 Infectious disease: bacterial
05132 Salmonella infection
130863228 (Casp3)
05133 Pertussis
130863228 (Casp3)
05134 Legionellosis
130863228 (Casp3)
05152 Tuberculosis
130863228 (Casp3)
09174 Infectious disease: parasitic
05146 Amoebiasis
130863228 (Casp3)
05145 Toxoplasmosis
130863228 (Casp3)
09164 Neurodegenerative disease
05010 Alzheimer disease
130863228 (Casp3)
05012 Parkinson disease
130863228 (Casp3)
05014 Amyotrophic lateral sclerosis
130863228 (Casp3)
05016 Huntington disease
130863228 (Casp3)
05020 Prion disease
130863228 (Casp3)
05022 Pathways of neurodegeneration - multiple diseases
130863228 (Casp3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
130863228 (Casp3)
05416 Viral myocarditis
130863228 (Casp3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
130863228 (Casp3)
04932 Non-alcoholic fatty liver disease
130863228 (Casp3)
04933 AGE-RAGE signaling pathway in diabetic complications
130863228 (Casp3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
130863228 (Casp3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
cnl01002
]
130863228 (Casp3)
Enzymes [BR:
cnl01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
130863228 (Casp3)
Peptidases and inhibitors [BR:
cnl01002
]
Cysteine peptidases
Family C14: caspase family
130863228 (Casp3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Other DBs
NCBI-GeneID:
130863228
NCBI-ProteinID:
XP_057609118
LinkDB
All DBs
Position
20:complement(31101396..31121698)
Genome browser
AA seq
277 aa
AA seq
DB search
MENNETTVDSKSTNNFEVKTIHGSKSMDSGMYLDNSYKMDYPEMGVCIIINNKNFHKSTG
MTPRSGTDVDAANLRETFMSLKYEVRNKNDLTREEIVELMDKVSKEDHSKRSSFVCVILS
HGDEGIIFGTNGPVDLKKLTSYFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSATDD
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKLHAHKLEFMHILTRVN
RKVATEFESFSHDSTFHAKKQIPCIVSMLTKDLYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacaacgaaaccacagtggattccaaatccactaataattttgaagtaaagacc
atacacggaagcaaatcaatggattctggaatgtatctggacaatagttacaaaatggat
tatcctgaaatgggtgtgtgtataataatcaataataagaactttcataaaagcactgga
atgacacctcgctctggtactgatgtcgatgcagccaacctcagagagacattcatgagc
ctaaagtatgaagtccggaataagaatgatctaactcgtgaagaaattgtggaattgatg
gataaagtctctaaagaggaccacagcaagaggagcagttttgtttgtgtgattctaagc
catggtgacgaaggaatcatttttggaaccaatgggcccgttgacctaaaaaagttaact
agttacttcagaggagactactgccgaagtctaacaggaaaacccaaactcttcatcatt
caggcctgccggggtacggagctggactgtggcattgagacagacagtgcaactgatgat
gatatggcgtgccagaagataccagtggaagccgacttcctgtatgcttactccacagca
cccggttactactcctggaggaattcaaaggacgggtcctggttcatccagtcactttgt
gccatgctgaagctgcatgcacacaagcttgagtttatgcacatcctcactcgcgtgaac
cggaaggtagcgacagaatttgagtccttctcccatgactccacttttcatgcaaagaaa
cagattccgtgcattgtgtctatgctcacaaaagatctctacttttatcactaa
DBGET
integrated database retrieval system